SRx HEALTH SOLUTIONS, INC.

SRXH

CIK 0001471727 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$3M
↓-60.8% -$4Mvs FY2024 (Q4)
Gross Profit
$1M
↓-59.5% -$2Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
53/100
  • Profitability
    100ROIC 28.5% (10% = solid, 20%+ = moat)
  • Liquidity
    90Current Ratio 2.29 (above 1.5 = solid)
  • Leverage
    100D/E -0.04 (under 0.5 = conservative)
  • Efficiency
    26Asset Turnover 0.54x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -60.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin -135.0% · trend -28.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$7K
investment in PP&E
Stock buybacks (TTM)
$137K
share count reduction
Stock-based comp (TTM)
$5M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$27M
everything owned
Total liabilities
$24M
everything owed
Stockholders' equity
$4M
shareholder claim
Net debt
$14M
LT debt minus cash

Recent performance · 76 quarters

Revenue↓-60.8% -$4M
$3M
Net Income↓-116.3% -$5M
$-9M
Free Cash Flow↓-301.4% -$4M
$-3M
Operating Margin
-135.0%

Drill down